Non-Melanoma Skin Cancers Coverage from Every Angle
Editor:
Karl D. Lewis, MD
Advertisement
Advertisement

Videos

Theresa M. Medina, MD, on Basal Cell Carcinoma and Immunotherapy

Karl D. Lewis, MD, on the Role of Adjuvant Immunotherapy in NMSC

Theresa M. Medina, MD, on Treating Cutaneous Squamous Cell Carcinoma With Cemiplimab-rwlc

Karl D. Lewis, MD, on Drug Therapy: Expanding Treatment Options

Eve Maubec, MD, PhD, on Cutaneous Squamous Cell Carcinoma: Update on Trials

Chrysalyne Schmults, MD, on Basal Cell Carcinoma: Treatment Research Update

Chrysalyne Schmults, MD, on Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma: Treatment Pipeline

Kim A. Margolin, MD, on the Emerging Role of Medical Oncologists in Treating Non-Melanoma Skin Cancers

Eric Roeland, MD, on Prophylactic Strategies for Highly Emetogenic Chemotherapy

Charles von Gunten, MD, PhD, on Opioids for Managing Cancer Pain

Steven M. Horwitz, MD, on SYK/JAK Inhibitor Treatment for T-Cell Lymphomas

Karl Lewis, MD, on a Phase II Study of Cemiplimab for Basal Cell Carcinoma

Chrysalyne D. Schmults, MD, MSCE, on Squamous Cell Carcinoma: Treatment/Costs Study Findings

Simron Singh, MD, MPH, on Patient-Centered Care: Measuring Experience

Betty R. Ferrell, PhD, on the Impact of Immunotherapy on Patients' Well-Being

Neeraj K. Arora, PhD, on Patient-Centered Care in Clinical Practice

Jeremy Warner, MD, on Patient Navigation: The Proactive Approach

Emily S. Ruiz, MD, MPH, on Squamous Cell Carcinoma: Expert Perspective

Danny Rischin, MD, on Cemiplimab for Metastatic Squamous Cell Carcinoma

Chrysalyne D. Schmults, MD, MSCE, and Squamous Cell Carcinoma: Risk of Recurrence

The JNCCN Spotlight

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.